<DOC>
	<DOCNO>NCT02631512</DOCNO>
	<brief_summary>The aim current study support performance safety WoulganÂ® treatment diabetic foot ulcer comparison commercially available hydrogel Intrasite . Healing untoward medical event evaluate .</brief_summary>
	<brief_title>Evaluation Woulgan Diabetic Foot Ulcer</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<criteria>Type I II diabetes mellitus . Target ulcer area 0.5 5 sqcm , 4 week old . Anklebrachial pressure index 0.7 . Ulcers due nondiabetic etiology . Uncontrolled diabetes define HbA1c 70 mmol/mol insufficient nutritional status . Ulcers older 1 year . Any gangrene , osteomyelitis , cellulitis , Charcot osteoarthropathy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>